ConductScience.org, home

Paper2327768

Ofloxacin versus co-trimoxazole for prevention of infection in neutropenic patients following cytotoxic chemotherapy.

Liang RH and 6 others. Antimicrob Agents Chemother, 1990. Cited by 69 papers, by iCite.

Cite this record

ConductScience Library. Ofloxacin versus co-trimoxazole for prevention of infection in neutropenic patients following cytotoxic chemotherapy. Papers, record 2327768. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/2327768

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Ofloxacin versus co-trimoxazole for prevention of infection in neutropenic patients following cytotoxic chemotherapy.
PubMed
Journal
Antimicrob Agents Chemother
PubMed
Year
1990
PubMed
Publication types
Clinical Trial, Comparative Study, Journal Article, Randomized Controlled Trial
PubMed
Citations, by iCite
69
iCite
Relative citation ratio, by iCite
3.5
iCite
Revised in PubMed
2021-05-26
PubMed

Authors7

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Liang RHR H
2Yung RWR W
3Chan TKT K
4Chau PYP Y
5Lam WKW K
6So SYS Y
7Todd DD

Source PubMed

Download CSV of authors

Topics16

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
AgranulocytosisMajor topic
Antineoplastic AgentsMajor topic
Bacterial InfectionsMajor topic
NeutropeniaMajor topic
OfloxacinMajor topic
Trimethoprim, Sulfamethoxazole Drug CombinationMajor topic
Adolescent
Adult
Aged
Child
Female
Gram-Negative Bacteria
Humans
Male
Microbial Sensitivity Tests
Middle Aged

Source PubMed

Download CSV of topics

References13

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
16842003Selective antimicrobial modulation as prophylaxis against infection during granulocytopenia: trimethoprim-sulfamethoxazole vs. nalidixic acid.J Infect Dis1983https://conductscience.org/library/papers/6842003PubMed
26437716Infection prophylaxis in the patient with bone marrow failure.Clin Haematol1984https://conductscience.org/library/papers/6437716PubMed
33010716Norfloxacin versus vancomycin/polymyxin for prevention of infections in granulocytopenic patients.Am J Med1986https://conductscience.org/library/papers/3010716PubMed
43740683Confidence intervals for reporting results of clinical trials.Ann Intern Med1986https://conductscience.org/library/papers/3740683PubMed
53091137Management of infection in the neutropenic patient.Br Med J (Clin Res Ed)1986https://conductscience.org/library/papers/3091137PubMed
63538962Oral norfloxacin for prevention of gram-negative bacterial infections in patients with acute leukemia and granulocytopenia. A randomized, double-blind, placebo-controlled trial.Ann Intern Med1987https://conductscience.org/library/papers/3538962PubMed
73284340Comparison of norfloxacin with cotrimoxazole for infection prophylaxis in acute leukemia. The trade-off for reduced gram-negative sepsis.Am J Med1988https://conductscience.org/library/papers/3284340PubMed
83471178Effect of oral ofloxacin on fecal bacteria in human volunteers.Antimicrob Agents Chemother1987https://conductscience.org/library/papers/3471178PubMed
93495732Successful intermittent chemoprophylaxis for Pneumocystis carinii pneumonitis.N Engl J Med1987https://conductscience.org/library/papers/3495732PubMed
103297617Ofloxacin. A review of its antibacterial activity, pharmacokinetic properties and therapeutic use.Drugs1987https://conductscience.org/library/papers/3297617PubMed
113300532
Selective gut decontamination with nalidixic acid or trimethoprim-sulfamethoxazole for infection prophylaxis in neutropenic cancer patients: relationship of efficacy to antimicrobial spectrum and timing of administration.
Antimicrob Agents Chemother1987https://conductscience.org/library/papers/3300532PubMed
123325254Development of resistance to ofloxacin.Drugs1987https://conductscience.org/library/papers/3325254PubMed
133466563Infection prophylaxis in acute leukemia: a comparison of ciprofloxacin with trimethoprim-sulfamethoxazole and colistin.Ann Intern Med1987https://conductscience.org/library/papers/3466563PubMed

Download CSV of references

Cited by17

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 69 citations.

PMIDTitleJournalYearIn PapersSource
39704726The effect of combining antibiotics on resistance: A systematic review and meta-analysis.Elife2024https://conductscience.org/library/papers/39704726PubMed
28874042Adverse drug reaction monitoring during antimicrobial therapy for septicemia patients at a university hospital in New Delhi.Korean J Intern Med2018https://conductscience.org/library/papers/28874042PubMed
25269391Prophylaxis for Pneumocystis pneumonia (PCP) in non-HIV immunocompromised patients.Cochrane Database Syst Rev2014https://conductscience.org/library/papers/25269391PubMed
22258955Antibiotic prophylaxis for bacterial infections in afebrile neutropenic patients following chemotherapy.Cochrane Database Syst Rev2012https://conductscience.org/library/papers/22258955PubMed
15714332Fluoroquinolone resistance of Escherichia coli at a cancer center: epidemiologic evolution and effects of discontinuing prophylactic fluoroquinolone use in neutropenic patients with leukemia.Eur J Clin Microbiol Infect Dis2005https://conductscience.org/library/papers/15714332PubMed
8834911Emergence of fluoroquinolone-resistant Escherichia coli in fecal flora of cancer patients receiving norfloxacin prophylaxis.Antimicrob Agents Chemother1996https://conductscience.org/library/papers/8834911PubMed
8460916Oral enoxacin for infection prevention in adults with acute nonlymphocytic leukemia. The Enoxacin Prophylaxis Study Group.Antimicrob Agents Chemother1993https://conductscience.org/library/papers/8460916PubMed
8203838A randomized trial of roxithromycin in patients with acute leukemia and bone marrow transplant recipients receiving fluoroquinolone prophylaxis.Antimicrob Agents Chemother1994https://conductscience.org/library/papers/8203838PubMed
8187783Strategy for antibiotic therapy in febrile neutropenic patients on selective antibiotic decontamination.Eur J Clin Microbiol Infect Dis1993https://conductscience.org/library/papers/8187783PubMed
8031031Emergence of fluoroquinolone-resistant Escherichia coli at a cancer center.Antimicrob Agents Chemother1994https://conductscience.org/library/papers/8031031PubMed
7689455Use of the quinolones for the prophylaxis and therapy of infections in immunocompromised hosts.Drugs1993https://conductscience.org/library/papers/7689455PubMed
7625811Concentration of pefloxacin in feces during infection prophylaxis in neutropenic patients.Antimicrob Agents Chemother1995https://conductscience.org/library/papers/7625811PubMed
2127348In vitro activity of sparfloxacin (CI-978; AT-4140) against clinical isolates from cancer patients.Antimicrob Agents Chemother1990https://conductscience.org/library/papers/2127348PubMed
2050424Ofloxacin versus trimethoprim-sulfamethoxazole for prevention of infection in patients with acute leukemia and granulocytopenia.Infection1991https://conductscience.org/library/papers/2050424PubMed
1723377Ofloxacin. A reappraisal of its antimicrobial activity, pharmacology and therapeutic use.Drugs1991https://conductscience.org/library/papers/1723377PubMed
1468518Selective decontamination in neutropenic patients.Epidemiol Infect1992https://conductscience.org/library/papers/1468518PubMed
1319865The quinolones. An overview of their pharmacology.Clin Pharmacokinet1992https://conductscience.org/library/papers/1319865PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/2327768

GET https://conductscience.org/api/papers/v1/2327768/authors